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Background
Often preceded by early-life wheezing, asthma is the
most common chronic disease of childhood. In view of
the emerging microflora hypothesis of allergic disease,
probiotics have been proposed for the prevention and
treatment of allergic disorders including asthma, but
clinical studies have yielded conflicting results. We
undertook a systematic review and meta-analysis of
randomized controlled trials to evaluate the association
of probiotic use during pregnancy or infancy with
childhood asthma and wheeze.
Methods
Following a registered protocol (PROSPERO
CRD42013004385), we searched MEDLINE, EMBASE,
and CENTRAL from inception to February 2013, plus the
World Health Organization’s International Clinical Trials
Registry Platform and relevant conference proceedings for
the preceding 5 years. Included trials and relevant reviews
were forward searched in Web of Science. Two reviewers
independently identified randomized controlled trials
evaluating probiotics administered during pregnancy or
the first year of life. The primary outcome was clinician-
diagnosed asthma; secondary outcomes included wheeze
and lower respiratory tract infection.
Results
We identified 20 eligible trials involving 4866 children.
Studies were heterogeneous in the type and duration of
probiotic supplementation, and duration of follow up.
Two trials conducted follow-up at or beyond 6 years of
age, and no trials were powered for asthma detection.
We adjudicated most trials (16/20) to be of unclear
or high risk of bias. Among 2781 infants enrolled in
8 studies contributing asthma data, the risk ratio of
clinician-diagnosed asthma in participants randomized
to receive probiotics was 0.96 (95% confidence interval
[CI] 0.71 to 1.29, I2 = 13%). The risk ratio of incident
wheeze was 0.95 (95%CI 0.85 to 1.07, I2 = 0%, 8 trials,
1770 infants). Among 1364 infants enrolled in 6 trials,
the risk ratio of lower respiratory tract infection follow-
ing probiotic use was 1.26 (95%CI 0.99 to 1.61, I2 = 0%).
Conclusions
We found no evidence to support a protective associa-
tion between perinatal administration of probiotics and
clinician-diagnosed asthma or childhood wheeze. There
is currently insufficient evidence from randomized con-
trolled trials to recommend probiotics for the primary
prevention of these disorders. Extended follow up of
existing trials, along with further clinical and basic
research, are required to accurately define the role of
probiotics in the prevention of childhood asthma.
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